COMPANY
Teva Pharmaceuticals USA
Teva Pharmaceuticals USA: trial sponsor, recalling firm for Desmopressin, Octreotide, as stated by public registers.
TRIAL SPONSOR
Sponsors registered clinical trials of the peptide.
| Desmopressin | 1 registered trial Trial register ClinicalTrials.gov |
|---|
RECALLING FIRM
Recalled a product naming the peptide (FDA enforcement report).
| Desmopressin | Class II recall, Terminated, 2020-02-12 Regulator openFDA |
|---|---|
| Desmopressin | Class II recall, Terminated, 2021-03-03 Regulator openFDA |
| Octreotide | Class II recall, Terminated, 2021-08-25 Regulator openFDA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.